Brain plasticity and pathology in psychiatric disease: Sites of action for potential therapy

Current Opinion in Pharmacology

Volumn 3, Issue 1, 2003, Pages 33-40

  Spedding, Michael ^a   Neau, Isabelle ^a   Harsing, Laszlo ^b  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCINEURIN; CALCIUM; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP; CYCLOTHIAZIDE; CYTOKINE; FLUOXETINE; GLUTAMATE RECEPTOR; KETAMINE; MONOAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIN; PHENCYCLIDINE; PHOSPHOPROTEIN PHOSPHATASE 1; PLACEBO; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; TIANEPTINE;

AMYGDALOID NUCLEUS; ANIMAL CELL; BRAIN FUNCTION; BRAIN NERVE CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TARGETING; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; LONG TERM POTENTIATION; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTRANSMISSION; NEUROTROPISM; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STRESS; SYMPTOMATOLOGY; SYNAPSE; TREATMENT PLANNING;

ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; HUMANS; MENTAL DISORDERS; NEURONAL PLASTICITY;

EID: 0037304064     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00008-5     Document Type: Review

References (68)

1. Wooley CS, McEwen BS: Roles of estradiol and progesterone in regulation of hippocampal dendritic spione density during the estrous cycle in the rat. J Comp Neurol 1993, 336:293-306.
2. Knott GW, Quairiaux C, Genoud C, Welker E: Formation of dendritic spines with GABAergic synapses induced by whisker stimulation in adult mice. Neuron 2002, 34:265-273.
3. Marrone DF, Petit TL: The role of synaptic morphology in neural plasticity: structural interactions underlying synaptic power. Brain Res Rev 2002, 38:291-308.
4. Rioult-Pedotti MS, Friedman D, Donoghue JP: Learning-induced LTP in neocortex. Science 2000, 290:533-536.
5. Genoux D, Haditsch U, Knobloch M, Michalon A. Storm D, Mansuy IM: Protein phosphatase 1 is a molecular constraint of learning and memory. Nature 2002, 418:970-975.
6. Barry MF, Ziff EB: Receptor trafficking and the plasticity of excitatory synapses. Cur Opin Neurobiol 2002, 12:279-286.
7. Buzsaki G: Theta oscillations in the hippocampus. Neuron 2002, 33:325-340.
8. Sheng M, Sala C: PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 2001, 24:1-29.
9. Piccini A. Malinow R: Critical postsynaptic density 95/disc large/zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J Neurosci 2002, 22:5387-5392.
10. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psych 1997, 54:597-608.
11. Skolnick P: Antidepressants for the new millennium. Eur J Pharmacol 1999, 375:31-40.
12. Black IB: Neurotropic selection and synaptic plasticity. In Brain and Mind: Evolutionary Perspective. Edited by Gazzaniga MS, Altman JS. Strasbourg; 1998:43-49.
13. Messaoudi E, Ying SW, Kanhema T, Croll SD, Bramham CR: Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 2002, 22:7453-7461.
14. Tao X, West AE, Chen WG, Corfas G, Greenberg ME: A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 2002, 33:315-316.
15. Cohen-Cory S: BDNF modulates, but does not mediate, activity-dependent branching and remodeling of optic axon arbors in vivo. J Neurosci 1999, 19:9996-10003.
16. Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW: Estrogen and exercise interact ot regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci 2001, 14:1992-2002.
17. Russo-Neustadt A, Beard RC, Cotman CW: Exercise, antidepressant medications, and enhanced brain derive neurotrophic factor expression. Neuropsychopharmacol 1999, 21:679-682.
18. McLean Bolton M, Pittman AJ, Lo DC: Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 2000, 20:3221-3232.
19. Lauterborn JC, Poulsen FR, Stinis CT, Isackson PJ, Gall CM: Transcript-specific effects of adrenalectomy on seizure-induced BDNF expression in rat hippocampus. Mol Brain Res 1998, 55:81-91.
20. Danter R, Bluthé RM, Gheusi G, Cremona S, Layé S, Pamet P, Kelley KW: Molecular basis of sickness behavior. Ann J NY Acad Sci USA 1998, 856:132-138.
21. Engert F, Bonhoeffer T: Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 1999, 399:66-70.
22. Star EN, Kwiatkowski DJ, Murthy VN: Rapid turnover of actin in dendritic spines and its regulation by activity. Nat Neurosci 2002, 5:239-246.
23. Johansson BB, elichenko PV: Neuronal plasticity and dendritic spines: effects of environmental enrichment on intact and positischemic rat brain. J Cereb Blood Flow Metab 2002, 22:89-96.
24. Yuste R, Bonhoeffer T: Morpholocial changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001, 24:1071-1089.
25. Kempermann G, Gast D, Gage FH: Neuroplasticity in old age: sustained fivefold indution of hippocampal neruogenesis by long-term environmental enrichment. Ann Neurol 2002, 52:135-143.
26. Nakatomi H, Kuriu T, Okabe S, Yamamoto SI, Hatano O, Kawahara N, Tamua A, Kirino T, Nakafuku M: Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002, 110:429-441.
27. Guden H, Tassin J-P, Jay TM: Integrity of the mesocortical dopaminegic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. Neuroscience 1999, 94:1019-1027.
28. Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C, Felder C, Gatley SJ, Ding YS, Hitzemann R, Pappas N: Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatr 2000, 157:75-80.
29. McEwen BS: Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
30. Posthuma D, de Geus EJ, Baare WF, Hulshoff Pol HE, Kahn RS, Boomsma DI: The association between brain volume and intelligence is of genetic origin. Nat Neurosci 2002, 5:83-84.
31. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T: Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatr 2002, 7:302-310.
32. Huber KM, Gallagher SM, Warren ST, Bear MF: Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002, 99:7746-7750.
33. O'Donnell WT, Warren ST: A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 2002, 25:315-338.
34. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ: Mechanism for the learning deficits in a mouse model of neurofibromatatosis type 1. Nature 2002, 415:526-530.
35. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatr 1987, 44:660-669.
36. Young KA, Manaye KF, Liang C, Hicks PB, German DC: Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatr 2000, 47:944-953.
37. Lauer M, Senitz D, Beckmann H: Increased volume of the nucleus accumbens in shizophrenia. J Neural Transm 2001, 108:645-660.
38. Meyer-Lindenberg A. Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Faith Berman K: Reduced prefrontal activity predicts exaggerated striatal dopaminirgic function in schizophrenia. Nat Neurosci 2002, 5:267-271.
39. Gur RC, Gunning-Dixon F, Bilker WB, Gur RE: Sex differences in temporo-limbic and frontal brain volumes of healthy adults. Cereb Cortex 2002, 12:998-1003.
40. Harrison PJ: The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122:593-624.
41. Cotter D, Mackay , Landau S, Kerwin R, Everall I: Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatr 2001, 58:545-553.
42. Rajkowska G, Selemon LD, Goldman-Rakic PS: Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntingon disease. Arch Gen Psychiatr 1998, 55:215-224.
43. Hirayusu Y, Shento ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz fa, McCarley RW: Subgenual cingulat cortex volume in first-episode psychosis. Am J Psychiatr 1999, 156:1091-1093.
44. Yamasaki H, LaBar KS, McCarthy G: Dissociable prefrontal brain systems for attention and emotion. Proc Natl Acad Sci USA 2002, 99:11447-11451.
45. Gógtay N, Giedd J, Rapoport JL: Brain development in healthy, hyperactive, and psychotic children. Arch Neurol 2002, 59:1244-1248.
46. Saposlky RM: Stress, the Aging Brain and the Mechanisms of Neuron Death. Cambridge, MA USA: MIT Press; 1992.
47. Watanabe Y, Gould E, Daniesis DC, Cameron H, McEwen BS: Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992, 222:157-162.
48. Hull AM: Neuroimaging findings in post-tramatic stress disorder. Systematic review. Br J Psychiatr 2002, 181:102-110.
49. Rutter ML: Psychosocial adversity and child psychopathology. Br J Psychaitr 1999, 174:480-493.
50. Meaney MJ: Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 2001, 24:1161-1192.
51. Mayberg HS: Limbic-cortical dsyregulation: a proposed model of depression, J Neuropsych and Clin Neurosci 1997. 9:471-481.
52. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA: Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatr 1999, 45:1085-1098.
53. Sheline YI, Wang PW, Gado MH, Csenansky JC, Vannier MW: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996, 93:3908-3913.
54. Sheline YI, Sanghavi M, Mintun MA, Gado MH: Depression duration but not age predicts hippocampal volume lose in medically healthy woment with recurrent major depression. J Neurosci 1999, 19:5034-50430.
55. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA: Prefrontal cortical dysfunction in depression determined by Wisconsin card sorting test performance. Am J Psych 1999, 156:780-782.
56. Ongur D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998, 95:13290-13295.
57. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr: Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994, 35:929-934.
58. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, Staib LH, Charney DS: Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatr 2002, 51:273-279.
59. q in the prefrontal cortex of conscious rats; antagonism by clozpine, and atagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors. Br J Pharmacol 2002, 135:56-78.
60. Legutko B, Li X, Skolnick P: Regulaton of BDNF exression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 2001, 40:1019-1027.
61. Lebrun C, pillière E, Lestage P: Effects of S 18986-1, a novel cognitice enhancer, on memory performances in an object recognition task in rats. Eur J Pharmacol 2000, 401:205-212.
62. Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM: Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neuron. J Neurosci 2000, 20:8-21.
63. Frerking M, Ohliger-Frerking P: AMPA receptors and kainate receptors encode different features of afferent activity. J Neurosci 2002, 22:7434-7443.
64. Andriamampandry C, Muller C, Schimidt-Mutter C, Gobaille S, Spedding M, Aunis D, Maitre M: Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol Pharmac 2002, in press.
65. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrung, Van Kampen M, Bartolomucci A, Fuchs E: Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001, 98:12796-12801.
66. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ: Changes in regiona brain glucose metabolism measured with positron emission tomogrphy after paroxetine treatment of major depression. Am J Psychiatr 2001, 158:899-905.
67. McKernan MG, Shinnick-Gallagher P: Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 1997, 390:607-611.
68. Rogan MT, Stäubli UV, LeDoux JE: Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997, 390:604-607.